BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2983346)

  • 1. Loss of polymorphic restriction fragments in malignant melanoma: implications for tumor heterogeneity.
    Dracopoli NC; Houghton AN; Old LJ
    Proc Natl Acad Sci U S A; 1985 Mar; 82(5):1470-4. PubMed ID: 2983346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of alleles at polymorphic loci on chromosome 2 in uveal melanoma.
    Mukai S; Dryja TP
    Cancer Genet Cytogenet; 1986 May; 22(1):45-53. PubMed ID: 3006911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma.
    Millikin D; Meese E; Vogelstein B; Witkowski C; Trent J
    Cancer Res; 1991 Oct; 51(20):5449-53. PubMed ID: 1680551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity at polymorphic chromosomal loci in patients with malignant melanoma.
    Orita M; Murakami Y; Ishihara K; Sekiya T
    J Invest Dermatol; 1989 May; 92(5 Suppl):280S-283S. PubMed ID: 2565933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity for 10q22-10qter in malignant melanoma progression.
    Herbst RA; Weiss J; Ehnis A; Cavenee WK; Arden KC
    Cancer Res; 1994 Jun; 54(12):3111-4. PubMed ID: 8205526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression.
    Dracopoli NC; Harnett P; Bale SJ; Stanger BZ; Tucker MA; Housman DE; Kefford RF
    Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4614-8. PubMed ID: 2734311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity for loci on chromosome 17p in human malignant astrocytoma.
    Fults D; Tippets RH; Thomas GA; Nakamura Y; White R
    Cancer Res; 1989 Dec; 49(23):6572-7. PubMed ID: 2573417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma.
    Toguchida J; Ishizaki K; Sasaki MS; Ikenaga M; Sugimoto M; Kotoura Y; Yamamuro T
    Cancer Res; 1988 Jul; 48(14):3939-43. PubMed ID: 2898286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity of DQ alpha gene in human malignant melanoma.
    Castelli C; Mazzucchelli F; Sensi M; Fossati G; Parmiani G
    Tumori; 1989 Aug; 75(4):378-82. PubMed ID: 2573190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma.
    Ohta M; Berd D; Shimizu M; Nagai H; Cotticelli M-G ; Mastrangelo M; Shields JA; Shields CL; Croce CM; Huebner K
    Int J Cancer; 1996 Mar; 65(6):762-7. PubMed ID: 8631588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infrequent loss of chromosomal heterozygosity in human stomach cancer.
    Wada M; Yokota J; Mizoguchi H; Sugimura T; Terada M
    Cancer Res; 1988 Jun; 48(11):2988-92. PubMed ID: 2835150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal allele loss in primary cutaneous melanoma is heterogeneous and correlates with proliferation.
    Böni R; Matt D; Voetmeyer A; Burg G; Zhuang Z
    J Invest Dermatol; 1998 Mar; 110(3):215-7. PubMed ID: 9506438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction to homozygosity and gene amplification in central nervous system primitive neuroectodermal tumors of childhood.
    Raffel C; Gilles FE; Weinberg KI
    Cancer Res; 1990 Feb; 50(3):587-91. PubMed ID: 1967549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rearrangement of chromosome band 11q13 in HeLa cells.
    Jesudasan RA; Slovak ML; Sen S; Srivatsan ES
    Anticancer Res; 1994; 14(5A):1727-33. PubMed ID: 7847806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allelotypes of primary cutaneous melanoma and benign melanocytic nevi.
    Healy E; Belgaid CE; Takata M; Vahlquist A; Rehman I; Rigby H; Rees JL
    Cancer Res; 1996 Feb; 56(3):589-93. PubMed ID: 8564976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity at autosomal and X-linked loci during tumor progression in a patient with melanoma.
    Dracopoli NC; Alhadeff B; Houghton AN; Old LJ
    Cancer Res; 1987 Aug; 47(15):3995-4000. PubMed ID: 2886213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential loss of maternal alleles in sporadic Wilms' tumour.
    Pal N; Wadey RB; Buckle B; Yeomans E; Pritchard J; Cowell JK
    Oncogene; 1990 Nov; 5(11):1665-8. PubMed ID: 1980007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biallelic deletions in INK4 in cutaneous melanoma are common and associated with decreased survival.
    Grafström E; Egyházi S; Ringborg U; Hansson J; Platz A
    Clin Cancer Res; 2005 Apr; 11(8):2991-7. PubMed ID: 15837753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome 5 allele loss in human colorectal carcinomas.
    Solomon E; Voss R; Hall V; Bodmer WF; Jass JR; Jeffreys AJ; Lucibello FC; Patel I; Rider SH
    Nature; 1987 Aug 13-19; 328(6131):616-9. PubMed ID: 2886919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Taqi RFLP of the human TGF alpha gene is significantly associated with cutaneous malignant melanoma.
    Hayward N; Nancarrow D; Ellem K; Parsons P; Kidson C
    Int J Cancer; 1988 Oct; 42(4):558-61. PubMed ID: 2902017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.